Aribio Lab adjusts stock option exercise price and reduces total outstanding options, limited shareholder impact

This amendment adjusts the exercise price of stock options granted on March 28, 2024 from 5,111 won to 5,018 won due to a subsequent rights offering.
Total outstanding options after this grant decreased from 369,083 shares to 138,168 shares, reducing potential dilution risk.
The current grant of 20,000 shares to a single employee represents only 0.074% of total outstanding shares, making the shareholder impact negligible.
[AI Summary]Aribio Lab's stock option amendment includes a downward exercise price adjustment and a reduction in total outstanding options, but the grant size is minimal, posing no material effect on stock price or shareholder value. The 20,000 share grant is a routine compensation for employee motivation, and no other financial changes are present.